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Abstract 
Objective: Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD) dementia have 
substantial clinical and biological overlap, with cognitive deficits typically observed in the 
executive and visuospatial domains. However, the neuropsychological profiles of the Mild 
Cognitive Impairment (MCI) stages of these disorders are not well understood.  
Methods: This systematic review examined existing literature on cognition in MCI due to LB 
disease (MCI-LB) and PD (PD-MCI) using an electronic search of seven databases (Medline, 
Embase, Psychinfo, PubMed, ProQuest, Scopus, ScienceDirect). MCI-LB results were 
reviewed narratively given the small number of resulting papers (n=7). Outcome variables 
from PD-MCI studies (n=13) were extracted for meta-analysis of standardised mean 
differences (SMD). 
Results: In MCI-LB, executive dysfunction and slowed processing speed were the most 
prominent impairments, while visuospatial and working memory functions were also poor. 
MCI-LB scored significantly lower on verbal memory tests relative to controls, but 
significantly higher than patients with MCI due to Alzheimer’s disease. Quantitative analysis 
of studies in PD-MCI showed a similar profile of impairment, with the largest deficits in 
visuospatial function (Benton Judgement of Line Orientation, SMD g=-2.09), executive 
function (Trail Making Test B, SMD g=-1.65), verbal ability (Naming Tests, SMD g=-.140) and 
working memory (Trail Making Test A, SMD g=-1.20). In both MCI-LB and PD-MCI, verbal and 
visuospatial memory retrieval was impaired, while encoding and storage appeared relatively 
intact. 
Conclusion: The findings of this systematic review indicate similar neuropsychological 
profiles in the MCI stages of DLB and PDD. Executive impairment may at least partially 
explain poor performance in other domains in these populations.  
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Introduction 
The construct of Mild Cognitive Impairment (MCI) encapsulates the intermediate 
stage between normal ageing and dementia in which cognitive decline is present yet 
activities of daily living are preserved (Albert et al., 2011; Flicker, Ferris, & Reisberg, 1991; 
Petersen et al., 1999). Development of the concept of MCI has supported a proliferation of 
studies of the prodromal stages of dementia, but most of the focus has been in MCI later 
diagnosed as Alzheimer’s disease (MCI-AD). Less work has been devoted to prodromal 
dementia with Lewy bodies (DLB), the second most common form of neurodegenerative 
dementia (Donaghy & McKeith, 2014). MCI-LB refers to MCI in individuals who will 
eventually be characterised as DLB, although DLB may have other prodromal presentations, 
such as REM sleep behaviour disorder (RBD). Whilst DLB is diagnosed when dementia 
precedes or accompanies parkinsonism (with the latter not necessarily occurring), another 
Lewy body dementia (LBD), Parkinson’s disease dementia (PDD), is defined as dementia 
occurring in the context of existing PD. The differentiation between DLB and PDD is 
operationalised by a ‘one year rule’, so that PDD is diagnosed when PD occurs a year or 
more before dementia. LBDs share neuropathological hallmarks (Lewy bodies and Lewy 
neurites; Aarsland, 2016; Boeve, 2012; Braak et al., 2003) and appreciable overlap in clinical 
presentation, including neuropsychiatric symptoms, autonomic features such as 
constipation and orthostatic dizziness, sleep disturbances, and response to cholinergic 
therapy (Burn & McKeith, 2003; Donaghy, O'Brien, & Thomas, 2015; Thomas et al., 2006). 
Indeed, the DLB/PDD Working Group has suggested that “there is no clinical symptom that 
absolutely distinguishes DLB and PDD” (p. 817, Lippa et al., 2007).  
Cohort studies suggest neuropsychological impairment in PD is not solely a late-stage 
issue, with subtle deficits detectable up to seven years before diagnosis (Darweesh et al., 
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2017). Because cognitive impairment may not always be detected or reported at 
presentation (Aarsland et al., 2008; reviewed in Goldman, 2014), many patients with an 
early alpha-synucleinopathy may be labelled as PD-MCI once parkinsonism advances, and 
PDD if loss of autonomy occurs, despite longer-standing cognitive deficits. Indeed, updated 
PD diagnostic criteria states that dementia at the time of parkinsonism onset is not an 
excluding factor for diagnosis (Postuma et al., 2015). Therefore, a PD-MCI diagnosis may 
also capture prodromal DLB and much existing work in PD-MCI may include prodromal DLB 
patients (Fujishiro, Nakamura, Sato, & Iseki, 2015; Massa et al., 2019). Massa et al. (2019), in 
recognition of the relevance of this diagnostic issue, recently reported on a small case series 
of patients that presented first with cognitive impairment and later developed motor 
symptoms consistent with PD (mean time to PD diagnosis=2.9 years, range 0.5-6.1), with 
nearly 50% having converted to dementia at follow-up. Massa et al. (2019) note that these 
patients meet both prodromal DLB (McKeith et al., 2017) and PD with cognitive 
presentation (Postuma et al., 2015) criteria. Moreover, utilising neuroimaging data, they 
conclude that, “the distinction between prodromal DLB and PD with a cognitive 
presentation seems blurry at the pathophysiological level, and these patients might be 
labelled as affected with prodromal LBD, as suggested by some authors (Donaghy and 
McKeith 2014; McKeith 2016)” (Massa et al., 2019, p. 14).  
As such, a review of the neuropsychological profile of MCI-LB should be informed by 
current research in cognition in PD-MCI. In terms of neuropsychological presentation, PDD 
and DLB may be indistinguishable when advanced, with cognitive deficits typically observed 
in the executive function (EF), visuospatial and memory domains (Aarsland, 2016). However, 
some differences between LBD groups have been reported, with DLB performing more 
poorly than PDD in tasks requiring EF and attentional ability (Downes et al., 1998; 
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Gnanalingham, Byrne, Thornton, Sambrook, & Bannister, 1997; Mondon et al., 2007). The 
current systematic review aims to evaluate existing research on cognition in MCI-LB and PD-
MCI. 
Methods 
Search strategy and scope 
The present review examined studies that used standardised tests of domain-level 
cognitive impairment in MCI associated with Lewy body disease. Key terms of the search 
(updated January 2019) of seven databases (Medline, Embase, Psychinfo, PubMed, 
ProQuest, Scopus, ScienceDirect) were chosen to target the three defining aspects of the 
studies of interest: (1) patients with clinical symptoms consistent with Lewy body 
neuropathology (“Lewy bodies,”), (2) patients in a pre-dementia stage (“MCI”), and (3) the 
use of neuropsychological methods (”neuropsychology”). Synonyms were created for each 
term and exploded with medical subject headings. Results were limited to human studies in 
peer-reviewed English language journals excluding reviews, meta-analyses, abstracts, case 
studies, commentaries, discussion papers, editorials and conference proceedings. Articles 
that were primarily imaging or eye tracking studies were removed. Titles and abstracts were 
reviewed independently by two authors (JC, BL) and discrepancies were discussed to 
achieve consensus.  
Inclusion and exclusion criteria 
Included studies measured at least one cognitive domain with an established 
neuropsychological task (previously published in ≥10 peer-reviewed journal articles). 
Composite scores of standardised tasks were accepted. Exclusion criteria were: unclear, 
insufficient or non-clinical PD diagnostic criteria; unspecified MCI classification; n<10 per 
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group; use of global measures (e.g. Mini-Mental State Exam); domain-level composite data 
only; or no healthy controls (HCs). Where studies included a third comparison group, patient 
and HC data were extracted. Baseline data were extracted from longitudinal studies.  
Data review, extraction and synthesis 
The following variables for each cognitive outcome measure were extracted: first 
author, year of publication, country of publication, participant numbers, participant age 
means and standard deviations (SD), PD diagnostic criteria, MCI criteria, disease duration, 
and outcome measure means, SDs and p-values. The direction of effect sizes (ES) was 
reversed as appropriate to reflect deficits as negative ES. Bias-corrected ES Hedges’ g 
(Hedges & Olkin, 1985) and 95% confidence interval (CI) based on the pooled estimate of SD 
were calculated and plotted by cognitive domain.  For commonly reported tasks, summary 
ES and 95% total CIs were calculated using Cochrane Reviews’ Review Manager (RevMan; 
The Nordic Cochrane Centre, 2014) fixed effect model and inverse variance. Due to different 
testing parameters and scoring across studies (i.e. z-scores), the summary ES were 
calculated as the standardised mean difference (SMD) to avoid overestimation of the overall 
difference (Hedges’ adjusted g; Deeks & Higgins, 2010). 
Results 
The evidence base 
The database search resulted in >7,000 articles; 6,286 after removing duplicates. 
Initial title review yielded 713 references that were screened by abstract. Articles were 
typically removed for topic irrelevance, especially not targeting early Lewy body disorders, 
only measuring cognition globally, or being primarily an imaging study. The full-text of the 
remaining 73 articles were reviewed by both reviewers and any ambiguity discussed for 
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consensus. Reasons for removal at full-text screen were: absence of HCs (n=7), unclear or 
insufficient PD diagnosis (n=11), irrelevant patient (n=10) or control (n=9) groups, 
inappropriate cognitive tasks (n=5), ≤10 participants tested (n=2), being primarily an imaging 
study (n=1), and cohort redundancy with other retained papers (n=8; the paper providing 
the most comprehensive cognitive task data was chosen). Studies excluded for absences of 
HCs (n=7) generally compared PD-MCI with PD with normal cognition (PD-NC) or normative 
data. They were reviewed informally for relevancy (see online supplement). 
MCI-LB results 
Table 1 displays details of retained papers. The search strategy yielded only one 
study in MCI-LB that met full inclusion criteria (Kemp et al., 2017). Six studies measured 
cognition in MCI-LB, but did not use a HC group. One paper had only nine patient subjects 
(Jicha et al.    , 2010). Given the small number and heterogeneity of MCI-LB results, these 
papers were retained for narrative review.  
[INSERT TABLE 1 HERE]. 
Kemp et al. (2017), the only paper meeting full inclusion criteria, considers 
neuropsychological scores as well as social cognitive ability. Patients are classified as 
“prodromal DLB” (n=37) for meeting MCI criteria (Petersen, 2004) and having at least two 
core symptoms of DLB (McKeith et al., 2005). After adjusting for age, sex and education 
level, prodromal DLB scored significantly lower than HCs (n=29) on 14 of 21 extracted 
outcome measures, representing executive function, attention and processing speed, 
working memory, visuospatial memory, visuoconstructive ability, and verbal memory. The 
largest effect sizes were reported on semantic verbal fluency (executive function; g = -1.65) 
and digit symbol substitution (attention/ processing speed, g = -1.16) tasks. The other 
significant effect sizes were in the g = -0.53 to -0.93 range. Prodromal DLB showed impaired 
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immediate and delayed free recall relative to controls. However, the authors suggested 
intact “real verbal memory (i.e. storage)” in the majority of their patients (29 of 37; 
outcome measure not specified), and emphasized retrieval deficits as related to executive 
impairments (Kemp et al., 2017). Kemp et al. (2017) also concluded that verbal memory 
(FCSRT total recall and recognition, g = -0.60) was better preserved than visual recognition 
memory (Delayed Matching to Sample-48 Items [g=-0.79]) in their sample. 
All studies in MCI-LB used clinical diagnostic criteria except for Jicha et al. (2010), 
where neuropathological diagnoses were utilised. No significant differences between MCI-
LB and MCI-AD in global cognitive measures (e.g. MMSE) were reported. Excluding Kemp 
(2017), 28 of the remaining 79 (35.44%) extracted outcome variables showed differential 
performance between MCI-LB and MCI-AD after bias-correction (see description in Table 1 
and individual statistics in the online supplement). This tally does not include individual 
tasks removed that did not meet a priori exclusion criteria for publication in at least 10 peer-
reviewed journals. 21 variables showed poorer performance by MCI-LB relative to MCI-AD in 
visuospatial, attention and psychomotor speed. Both Bussè et al. (2018) and Cagnin et al. 
(2015) reported poorer performance in MCI-LB in WM, visuospatial and visuoconstructive 
ability, and EF, with magnitudes ranging from medium (g=-0.56, Object Decision Visuospatial 
Test, Cagnin et al., 2015) to large (g=-0.95, Digit Span Backwards, Cagnin et al., 2015) and 
very large (g=-3.45, Pentagon Test number of angles, Busse, Hensel, Gühne, Angermeyer, & 
Riedel-Heller, 2006). Donaghy et al. (2018) showed deficits in MCI-LB relative to MCI-AD of 
medium effect size in attention (Digit Vigilance, g=-0.56), EF (difference between Choice and 
Simple Reaction Time, g=-0.53), and visuospatial function (Angle Task, g=-0.55).  Sadiq et al. 
(2017) reported impaired scores on EF (letter fluency, g=-0.62) and attention (Trails B, g=-
0.51), while Yoon, Kim, Moon, Yong, and Hong (2015) only showed impairment in EF (g=-
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0.72; Stroop Colour test) and there were no significant differences in Jicha et al. (2010) after 
bias-correction. MCI-LBs performed significantly better than MCI-AD on verbal memory 
outcome measures (immediate recall, delayed recall and recognition) in three studies (Bussè 
et al., 2018; Cagnin et al., 2015; Yoon et al., 2015) with generally large effect sizes (g=0.66 to 
3.80, mean g=1.82). 
The studies showing deficits in MCI-LB in the domains of WM and attention, EF and 
visuospatial function were not wholly consistent, as some outcome variables in the same 
domains did not reach significance. For example, Donaghy et al. (2018) reported significant 
differences in only one of the nine outcome measures of attention and psychomotor speed 
(Digit Vigilance). 
Additionally, both Yoon et al. (2015) and Sadiq et al. (2017) also compared MCI-LB/ 
DLB-MCI to an MCI-stable group at follow-up. In Yoon et al. (2015; 5 years of follow-up), 
MCI-LB was impaired in the domains of visuospatial ability and memory (ROCF recognition 
and copy), EF (Stroop Colour, verbal semantic fluencies), WM/attention (Digit Span 
Forwards and Backwards), and verbal learning and memory (SVLT delayed recall) relative to 
MCI that did not convert to dementia. Sadiq et al. (2017; mean follow-up 2.8 years) found 
that DLB-MCI patients are also impaired in EF (letter fluency) and visuoconstruction (clock 
drawing test) relative to stable-MCI. 
[INSERT TABLE 2 HERE]. 
PD-MCI evidence base 
Demographic and clinical characteristics of participants 
Details of quantitatively reviewed articles are summarised in Table 1 and group 
characteristics are summarised in Table 2. Some studies did not provide details of age (but 
were age-matched) or disease duration. For PD diagnosis, studies cited United Kingdom PD 
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Society Brain Bank criteria (UKPDS; Hughes, Daniel, Kilford, & Lees, 1992)  or equivalent, and 
National Institute of Neurological Disorders and Stroke criteria (Gelb, 1999). To define PD-
MCI, seven studies used MDS criteria (Litvan et al., 2012). The remaining studies used a mix 
of clinical and neuropsychological diagnostic criteria, including both normative and control 
data as impairment criteria. 
Exclusion of Tasks 
Unclear task information or use of unestablished tasks (<10 published peer-reviewed 
references) necessitated the removal of variables from 8 of 13 studies. While not leading to 
removal from analyses, details provided were often also insufficient regarding the length of 
delay in memory tasks. Only the two most commonly reported measures per task and paper 
were retained in order to focus synthesis and avoid redundancy (e.g. for card sorting tasks, 
“categories achieved” and “perseverative errors” were used). Similarly, closely related 
variables administered for more experimental rationales were removed to avoid 
redundancy (e.g. from Costa et al. (2015), “Drawings Copy” was extracted while “Drawings 
with Landmarks Copy” was not). Sums were not extracted if separate scores were also 
provided, for example with Digit Span Total (Yu et al., 2012).  
Domain level cognitive assessments 
Outcome measures were organised into the domains of WM, EF, visuospatial and 
verbal function, corresponding to their face validity. This conflicted with a number of papers 
that assigned outcome measures to domains of which they were not the primary target. For 
example, verbal fluency tasks were referred to as language or memory tasks in five papers 
when they are most commonly accepted as measures of EF (MacCarthy, 1972). Overall, 
every study showed worse performance in patients than HCs in at least one cognitive 
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domain. Table 2 displays the number of outcome variables retained in each domain for each 
group, after removal described above, and how many were impaired. Table 3 displays 
summary ES of frequently reported outcome variables. See online supplement for individual 
ES and CI, and for figures displaying data not included below. Across domains, there was a 
pattern of smaller ES reported by studies with larger sample sizes.  
 [INSERT TABLE 3 HERE]. 
Executive function, working memory and attention 
A variety of EF and WM tasks were used, with ES ranging from moderate (g=-0.45; Yu 
et al., 2012, semantic fluency) to very large (g=-2.47; Sanyal et al., 2014; semantic fluency). 
EF was the most frequently targeted domain. Commonly reported outcome measures were 
from card sorting, verbal fluency and Stroop tasks, with patients showing summary 
impairments in the medium (g=-0.63) to large (g=-1.30) range (Table 3). Verbal fluency 
tasks, commonly used measures of EF (Baddeley, 1996), can be separated into semantic and 
phonemic fluency paradigms. Both showed large ES (Fig. 1a and 1b), but PD-MCI was 
somewhat more impaired in semantic fluency tasks.  
PD-MCI showed a lower proportion of only 21 of 30 impaired WM variables, but with 
a similar range in summary ES (g=-0.52 to -1.65) as in EF. Six studies included WM measures 
that in particular require psychomotor speed, including Trails A and B. While both summary 
ES are large, there was greater impairment on Trails B, which requires executive functions, 
than Trails A. All four studies that used Trails B reported significant and large deficits (above 
1 SD), with a SMD of g=-1.65 [-1.93, -1.37]. A similar divergence was observed between Digit 
Span Forwards (g=-0.52) and Backwards (g=-0.69). 
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Visuospatial domain 
Patients performed significantly worse than controls on 30 of the 33 visuospatial 
memory variables. The largest SMD computed from the evidence base overall was in JOLO 
(g=-2.09; Benton, Hamsher, Varney, & Spreen, 1983), making visuospatial function the most 
frequently and severely impaired domain. Only Song, Kim, Jeong, Song, and Lee (2008) 
reported a lack of difference in visuospatial function (ROCF copy, immediate and delayed 
recall). Figure copying and recall was a common visuospatial paradigm, but recall conditions 
varied substantially in the length of delay. Summary ES for the PD-MCI group showed more 
pronounced deficits in figure copying than in either immediate or delayed recall. Song et al. 
(2008) also tested delayed figure recognition and found a moderate deficit in PD-MCI 
relative to controls (g=-0.60). However, potential outliers (Poletti et al., 2012; Sanyal et al., 
2014) complicate interpretation (Fig. 2).  
Six outcomes from 4 studies targeted the visuospatial component of WM, per 
fractionated models proposed by Baddeley and Hitch (1974), Logie and Pearson (1997), and 
others. These include the Corsi Test (Corsi, 1972) and Pattern Recognition Memory (Robbins 
et al., 1998). A summary ES computed from Corsi Tests administered by Poletti et al. (2012), 
Costa et al. (2015) and Biundo et al. (2014) suggested a moderate impairment in PD-MCI 
relative to controls, with Poletti et al. (2012) having the only significant finding. 
Verbal domain 
Patients performed significantly worse than controls in 30 out of 34 of the verbal 
domain variables. Each study that tested verbal learning and memory reported at least one 
significant difference between groups. However, three studies measuring verbal learning 
and memory did not find a significant difference between groups: CVLT in Galtier, Nieto, 
Lorenzo, and Barroso (2016), Hopkins Verbal Learning Test (HVLT) and Boston Naming Test 
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(BNT) in Song et al. (2008), and HVLT in Wang et al. (2015). Two-thirds of significant 
outcome variables pertained to word list recall tasks. Most immediate and delayed free 
recall scores indicated significant impairment, but the three studies measuring recognition 
did not show a significant difference between patients and controls. Very large ES were also 
found in Naming Tasks (g=-1.40). 
Discussion  
Summary of findings 
MCI-LB 
In this structured review, only one study on the cognitive profile of MCI-LB utilised a 
control group. Kemp et al. (2017) reported prodromal DLB to have a profile of diffuse 
impairments in the domains of EF, processing speed, attention, working memory, 
visuospatial ability and visuospatial construction, verbal memory and language. Kemp et al. 
(2017) provided evidence of immediate and delayed verbal recall deficits in prodromal DLB 
compared to controls, although recognition memory was intact. This study indicates that a 
substantial number of MCI-LB will present with verbal memory impairment at this early 
stage and it should not therefore be taken as a reliable indicator of prodromal AD (Kemp et 
al., 2017).  However, ES of verbal memory impairment reported in MCI-LB (g = -058; Kemp 
et al., 2017) were almost half that of the pooled estimate for PD-MCI (g = -1.25). 
Given that the largest deficits overall in prodromal DLB were in EF (g=-1.65) and 
processing speed (g=-1.16), it is possible that domain-general impairments could at least 
partly account for deficits across other cognitive functions (Kemp et al., 2017). Slowed speed 
of processing, executive dysfunction, or praxic and perceptual impairments in prodromal 
DLB could confound interpretation of deficits in more complex tasks such as visual 
construction or naming tests, as well as the greater impairments on visual versus verbal 
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memory scores reported by Kemp et al. (2017).  Executive dysfunction, for example, has the 
potential to impair cognition at various stages, including encoding and retrieval in the case 
of memory function, thereby compounding the impact (Luszcz & Bryan, 1999). Kemp et al.’s 
(2017) emphasis on the role of EF in prodromal DLB is in line with a recent report that 
another measure of EF (verbal fluency) had the highest predictive accuracy for conversion to 
DLB in idiopathic RBD patients (Génier Marchand et al., 2018). EF similarly emerges as a 
potential explanatory factor in PD-MCI results, as discussed further below.  
Only six other studies (Bussè et al., 2018; Cagnin et al., 2015; Donaghy et al., 2018; 
Jicha et al., 2010; Sadiq et al., 2017; Yoon et al., 2015) resulted from the systematic review 
and used MCI-AD rather than a control group for comparison. This illustrates both the 
dearth of neuropsychological research in MCI-LB and the current focus on AD in the field. 
However, the small number of results in this key population may also relate to the challenge 
of identifying MCI-LB patients. Both DLB and PDD are under-diagnosed, and regional 
(geographic) differences in prevalence rates suggest varying clinical awareness of Lewy body 
disease (Kane et al., 2018). The retained studies provided limited evidence for MCI-LB and 
MCI-AD differentiation, as only about a third of extracted measures differed between 
groups and the findings within domains are sometimes inconsistent, with MCI-LB 
statistically differing from MCI-AD on some but not all tasks in the same domain. Verbal 
learning and memory appeared preserved in MCI-LB relative to MCI-AD, in line with the 
pronounced memory encoding deficits of AD (Lange et al., 2002; Martin, Brouwers, Cox, & 
Fedio, 1985). However, without the use of HCs, it cannot be inferred that verbal impairment 
relative to controls should not be expected in MCI-LB cohorts.  
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PD-MCI  
Our quantitative analyses emphasise that there are significant deficits in PD-MCI 
relative to HCs. Overall, the highest proportion and most severe of deficits was observed in 
the visuospatial domain, although the verbal and EF domains were also consistently 
impaired. One of the largest differences between PD-MCI and controls was in Benton’s JOLO 
task (Benton et al., 1983). JOLO, unlike many other visuospatial tasks, requires minimal 
motor skill and is free of practice effects (Montse, Pere, Carme, Francesc, & Eduardo, 2001). 
As such it may be particularly useful in tracking cognitive decline with PD progression. There 
was less consistency in the attention and working memory data, with half of the papers 
showing deficits in some but not all reported tasks. Similarly, the magnitude of deficit on 
semantic verbal fluency tasks differed widely between studies, suggesting unreliability when 
quantifying the extent of executive dysfunction in patients. Our review found a slightly 
larger ES of impairment in semantic than phonemic verbal fluency tasks in PD-MCI, in line 
with findings from a meta-analysis in PD (Henry & Crawford, 2004). Semantic fluency tasks 
make demands on temporal functions and are typically challenging for AD patients (Henry, 
Crawford, & Phillips, 2004), while phonemic verbal fluency is more closely associated with 
frontal abilities (Troyer, Moscovitch, Winocur, Alexander, & Stuss, 1998). This suggests 
firstly that caution should be taken when utilizing semantic and phonemic verbal fluency 
tasks interchangeably as indicative of executive dysfunction, for example in the case of 
current PD-MCI criteria (Litvan et al., 2012). Secondly, this could suggest that co-occurring 
AD pathology accounts for semantic fluency impairment in PD-MCI. However, recent work 
by El-Nazer et al. (2019) concluded that PD and PD/AD mixed pathologies do not differ 
clinically and that cognitive deficits are associated with both LB and AD pathological burden. 
Specifically, greater Lewy body density was found in limbic and cortical structures in PD 
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patients with poor verbal fluency, but higher AD pathology was on trend in many of the 
same areas. 
Recall versus recognition in PD-MCI 
PD-MCI-associated deficits in figure copying (g=-1.56) were more pronounced than 
in recall (immediate g=-0.91 and delayed SMD g=-1.03 recall), although all ES were large. 
Conversely, visuospatial recognition is much less impaired (Song et al., 2008), as also 
emerged in the MCI-LB results. It is possible that complex figure recall is a more challenging 
task for both patients and controls, and thus less difference between groups is observed. 
The use of retention scores (the percentage of information lost or gained between copy and 
recall conditions) might provide more nuanced information on differential abilities (Shin, 
Park, Park, Seol, & Kwon, 2006). Recognition memory for word list stimuli seems similarly 
intact in PD-MCI, in contrast to deficits in both immediate and delayed recall conditions. 
This pattern of dysfunction in both the visuospatial and verbal domains in PD-MCI suggests 
impaired retrieval and relatively intact encoding and storage mechanisms (Shin et al., 2006). 
This supports the established retrieval deficit hypothesis of memory impairment in PD 
(Tröster & Fields, 1995; Whittington, Podd, & Kan, 2000), which argues that the cause of 
memory impairment is inability to retrieve material on demand rather than encoding or 
retention ability (Mahurin, Feher, Nance, Levy, & Pirozzolo, 1993). Given that a similar 
pattern emerged in MCI-LB (Kemp et al., 2017), this model may apply to other early alpha-
synucleinopathies. 
However, there has been increasing scrutiny of this hypothesis and evidence of 
recognition impairment in some patients (Higginson, Wheelock, Carroll, & Sigvardt, 2005; 
Whittington et al., 2000). Whittington (2000) found impairment in recognition in PD 
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participants without dementia, but not in newly diagnosed PD patients, and Bronnick, Alves, 
Aarsland, Tysnes, and Larsen (2011) found that early PD patients performed poorly on free 
recall, cued recall and recognition memory. Bronnick et al. (2011) attribute this impairment 
to encoding failure due to poor EF, rather than to impaired retrieval. Indeed, PD participants 
used fewer semantic clustering strategies to enhance their recall, and both strategy and EF 
explained significant variance in learning. Earlier, Gershberg and Shimamura (1995) and 
Hirst and Volpe (1988) had demonstrated that frontal lobe lesion patients were unable to 
capitalise on the potential semantic organisation present in word lists. It is likely that the 
prominent EF impairments in PD-MCI at least partly explain poorer performance on tasks of 
greater complexity, regardless of domain.  
Executive function weighting impairs performance in PD-MCI 
Impairment was found on only two-thirds of visuospatial WM measures despite the 
high proportion of visuospatial learning and memory tasks (91%) that show deficits in PD-
MCI. One question is why visuoconstructional ability impaired but not visuospatial WM? 
Figure copying such as ROCF is a complex task that requires executive functions such as 
sustained attention, planning and organisation (Shin et al., 2006), in addition to the 
visuospatial perception and processing that is required in visuospatial WM tasks like Corsi 
blocks. If executive demands are responsible for this divergence, this emphasises the 
methodological importance of locating the executive processes within tasks with face 
validity in other domains. However, even simple WM tasks such as Digits Forward could be 
argued to have an EF component (e.g. chunking) so this issue may speak more to the debate 
regarding multicomponent versus unitary models of WM (Cowan, 1999; Engle, Tuholski, 
Laughlin, & Conway, 1999) than to a salient difference in a patient population. 
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MCI classification 
Defining MCI neuropsychologically using domain cut-off scores may also have the 
potential for circularity in analyses in which neuropsychological performance is the 
phenotype of interest. In the PD-MCI, all but one study (Anderson, Simpson, Channon, 
Samuel, & Brown, 2013) defined groups using neuropsychological criteria. PD-MCI studies 
tend to utilise Movement Disorder Society (MDS) diagnostic criteria for MCI, which is based 
on neuropsychological cut-off scores by individual cognitive domain, typically between 1 
and 2 SDs. However, the specific magnitude of deficit required to be considered 
“impairment” has critical implications. Dalrymple-Alford et al. (2011) found that while only 
14% of a PD sample was considered PD-MCI when defined as two SDs below normative 
scores in at least two tests in a domain, this number increases to 89% if considered at one 
SD or more. In the latter scenario, 70% of clinically-defined HCs were also identified as MCI. 
To capture the breadth of impairment, MDS criteria stipulates that cognition should ideally 
be measured in five domains by at least two tasks, but this increases the likelihood of 
reaching significance on at least one measure. Few studies correct for multiple comparisons. 
Such a large amount of neuropsychological testing can also become unwieldy to report in 
entirety and encourages selection biases in presenting only significant results. Thus, 
choosing a battery poses a problem: decreasing the breadth may omit relevant individuals, 
but increased breadth often leads to contradictory findings within domains. The use of 
composite domain scores may help to overcome this methodological challenge and has 
been suggested to bypass task idiosyncrasy, avoid multiple comparisons, and increase 
power (Crane et al., 2012; Gibbons et al., 2012).  
While results suggest similarities in the neuropsychological profiles of MCI-LB and PD-MCI by 
domain, future work comparing these patient groups directly is warranted. For example, poorer 
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episodic memory ability might be expected in MCI-LB given evidence of greater co-occurrence of 
amyloid and tau pathology in DLB versus PDD (Jellinger & Korczyn, 2018). However, ES of verbal 
memory impairment reported in MCI-LB (g = -0.58; Kemp et al., 2017) were almost half that of the 
pooled estimate for PD-MCI (g = -1.25) in the present study. A potential explanation for this finding 
may be the greater variability expected in DLB (Nelson et al., 2010) and MCI-LB. Indeed, the validity 
of such direct comparisons of MCI subtypes (and MCI studies in the case of meta-analysis) may be 
challenged given the different definitional criteria for MCI currently in use. 
The present study targeted only controlled studies in early Lewy body dementias in order to 
avoid a number of potential confounding factors, such as order effects in large neuropsychological 
batteries. Moreover, many of the tasks have subtle differences in administration. For example, the 
RAVLT is regularly administered with Long Delay recall conditions of between 15 and 30 minutes 
and, optimally, patient scores should be compared with controls who have had the same specific 
retention interval. By using a local control group, there is also increased likelihood of equivalence 
between groups in unquantified socioeconomic and geographical variables. By only including studies 
with control groups, we utilised a robust search strategy towards a conservative meta-analysis. 
However, this approach does not assume that important insights will not be found in studies using 
other relevant patient groups, such as stable or reverting MCI patients, or normative data (see 
online supplement). For example, Yarnall et al. (2014) found a high prevalence of MCI in their 
incidence cohort and suggested that prominent executive dysfunction may account for poor 
performance in other domains, such as memory tasks, in line with the present review’s suggestions. 
Longitudinal studies also critically offer insight into cognitive trajectories in PD-MCI, and suggested 
that low baseline executive function, processing speed, visuospatial function and verbal memory 
were predictive of poorer outcomes at follow up (for example, see Pigott et al., 2015; Williams-Gray, 
Foltynie, Brayne, Robbins, & Barker, 2007). 
In conclusion, growing interest in MCI due to Lewy body disease necessitates a 
broader understanding of cognition in early disease. The present study aimed to capture 
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existing literature in neuropsychological functioning by focussing on studies in MCI-LB and 
PD-MCI. MCI-LB studies are limited, but provide evidence for impaired EF, speed of 
processing, visuospatial, WM and attentional abilities in comparison to controls and MCI-
AD. However, results within domains are at times inconsistent. PD-MCI show deficits in 
visuospatial, executive and verbal tasks. However, these results should be interpreted with 
caution due to issues of circularity. MCI as a stable finding has also been called into 
question, with 9% of individuals with establish MCI later “reverting” to normal cognition 
(Copeland & Schiess, 2013). Thus, while PD-MCI may retain utility in clinical settings, it may 
be inappropriate as an a priori definition of a patient group in neuropsychological research. 
Defining MCI clinically (e.g. by assessing independent function in daily activities, input from 
family members, neurological examination, global cognitive scales [MMSE] to rule out 
advanced or absent impairment, or biomarkers), rather than neuropsychologically, will 
serve to better capture the cognitive heterogeneity of early Lewy body dementias and allow 
for more nuanced analyses of the potential interrelatedness of deficits.  
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Tables 
Table 1. Details of all included studies (MCI-LB and PD-MCI). 
First author 
(year) 
Country Patient group Comparison 
group 
Design MCI criteria Diagnostic criteria Disease 
duration 
(months) 
Mean 
(SD) 
Domains 
measured 
Outcome 
measures 
impaired 
Type n Type n 
Bussè 
(2018) 
Italy Prodrom
al DLB 
19 Prodroma
l AD 
25 Cross-sectional 
with diagnosis after 
at least 3 years of 
follow up. 
Petersen (2004) McKeith et al. (2017), 
“DLB Possible”. 
- EF 2 of 3 
WM/att 2 of 3 
Verbal 0 of 7 
Visuospatial 4 of 5 
Cagnin 
(2015) 
Italy MCI-LB 25 MCI-AD  28 Retrospective 
analysis of records 
at first 
(predementia) visit. 
Absence of dementia (MMSE>26) and 
“functional impairment in everyday 
life”. 
Exclusion: inability to establish a 
definite diagnosis at follow-up and 
cognitive decline due to 
comorbidities. 
McKeith et al. (2005) - EF 2 of 2 
WM/att 1 of 2 
Verbal 0 of 2 
Visuospatial 4 of 10 
Donaghy 
(2018) 
UK MCI-LB 41 MCI-AD 24 Cross-sectional. Albert et al. (2011) McKeith et al. (2017), 
“DLB Probable”. 
- EF 1 of 1 
WM/att 1 of 9 
Verbal 0 of 3 
Visuospatial 1 of 1 
Jicha (2010) USA MCI-LB 9 MCI-AD 12 Retrospective 
analysis of records 
of neuropathically 
determined 
groups. 
Records reviewed for MCI criteria of 
2nd International Consensus Panel on 
MCI, Stockholm, Sweden (Winblad et 
al., 2004) including impairment of at 
least 1.5 SDs below age and education 
matched controls on “formal testing” 
(p. 1807). 
Neocortical DLB (below 
Braak stage IV) with no 
significant AD pathology 
or vascular disease), 
- EF 0 of 3 
WM/att 0 of 2 
Verbal  0 of 3 
Kemp 
(2017) 
France Prodrom
al DLB 
37 Healthy 
controls 
29 Cross-sectional. Petersen (2004) McKeith et al. (2005), 
“DLB Probable”. 
- EF 4 of 4 
WM/att 2 of 4 
Verbal 3 of 3 
Visuospatial 5 of 9 
Sadiq 
(2017) 
UK DLB-MCI 21 AD-MCI 107 Retrospective, 
unslected sample.. 
Petersen et al. (1997) McKeith et al. (2005), 
“DLB Probable”. 
21.6 
(13.2) 
EF 1 of 2 
WM/att 1 of 2 
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Verbal 0 of 2 
Visuospatial 0 of 1 
Yoon 
(2015) 
South 
Korea 
MCI-LB 18 MCI-AD  45 Prospective cohort.  With regards to matched controls: (1) 
scores below 16th percentile in at least 
one of five cognitive domains on the 
Seoul Neuropsychological Screening 
Battery (Yang, 2003), (2) scores above 
the 16th percentile on Korean Mini-
Mental State Examination, and (3) no 
impairments in Activities of Daily 
Living. 
McKeith et al. (2005) - EF 1 of 5 
WM/att 0 of 2 
Verbal 0 of 6 
Visuospatial 0 of 4 
Anderson 
(2013) 
UK PD-MCI 19 HC 16 Matched on age Score of 93 or less on Addenbrooke’s 
Cognitive Examination-Revised, no 
lower score limit (Komadina, 2011) 
Calne et al. (1992) Not given EF 3 of 4 
Biundo 
(2014)  
Italy PD-MCI 49 HC 18 Adjusted 
normative data: 
age, education 
MDS level II criteria (Litvan et al., 
2012) 
UKPDS (no reference) 109.7 
(72.0)  
EF 2 of 3 
WM/att 1 of 4 
Verbal all 
Visuospatial all 
Bocanegra 
(2015) 
Colombia PD-MCI 17 HC 17 Matched on age, 
education, sex 
MDS level I criteria (Litvan et al., 2012) UKPDS (Hughes et al., 
1992) 
Not given Verbal all 
Costa 
(2015) 
Italy PD-MCI 48 HC 20 Groups not 
matched 
MDS level II criteria (Litvan et al., 
2012) 
UKPDS (Hughes et al., 
1992) 
75.6 
(49.2)  
EF all 
WM/att 1 of 5 
Verbal all 
Visuospatial all 
Dalrymple-
Alford 
(2011) 
New 
Zealand 
PD-MCI 3 HC 34 Adjusted (z-
scores): age, 
education 
Neuropsychological scores 1.5 to 2 
SDs below normative data in one 
domain. 
UKPDS (Hughes et al., 
1992) 
Not given EF all 
WM/att all 
Verbal all 
Visuospatial all 
Galtier 
(2016) 
Spain PD-MCI 26 HC 20 Matched on age, 
education,  
intelligence, 
manual preference, 
sex 
MDS level II criteria (Litvan et al., 
2012) 
UKPDS (Hughes et al., 
1992) 
105.7 
(67.2)  
EF 2 of 4 
WM/att 0 of 1 
Verbal 3 of 4 
Visuospatial all 
Hessen 
(2016) 
Norway PD-MCI 13 HC 25 Groups not 
matched 
Clinical and neuropsychological 
criteria (National Institute on Aging-
Alzheimer’s Association). At least one 
of the six neuropsychological subtests 
impaired (1.5 SD or more below 
UKPDS (Berardelli et al., 
2013)  
25.2 (9.6)  EF all 
Verbal all 
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normative scores)  
Peraza 
(2017) 
UK PD-MCI 37 HC 30 Groups not 
matched 
MDS level II criteria (Litvan et al., 
2012) 
UKPDS (Hughes et al., 
2002) 
5.81 
(4.51)  
EF all 
WM/att all 
Poletti 
(2012) 
Italy PD-MCI 18 HC 100 Matched on age MDS level II criteria (Litvan et al., 
2012) 
UKPDS (Hughes et al., 
1992) 
11.0 (8.8)  EF 7 of 8 
WM/att all 
Verbal all 
Visuospatial all 
Sanyal 
(2014) 
India PD-MCI 90 HC 280 Matched on age, 
sex 
Clinical Criteria. UKPDS (Conditions, 
2006) 
34.8 
(55.2)  
EF all 
Verbal all 
Visuospatial 1 of 2 
Song (2008) Korea PD-MCI 20 HC 33 Groups not 
matched 
Neuropsychological scores of at least 
2 SD below control group in at least 
one test. 
UKPDS (Hughes et al., 
1992) 
57.6 
(29.9)  
EF all 
WM/att 1 of 2 
Verbal 2 of 4 
Visuospatial 1 of 4 
Wang 
(2015) 
China PD-MCI 96 HC 163 Matched on age, 
gender, education 
MDS level II criteria (Litvan et al., 
2012) 
UKPDS (Hughes et al., 
1992) 
61.2 
(41.0)  
EF all 
WM/att all 
Verbal 3 of 4 
Visuospatial all 
Yu (2012) Taiwan PD-MCI 94 HC 84 Matched on age, 
education, sex 
Neuropsychological scores of at least 
1.5 SD below normative mean (or 
below the fifth percentile) of 
normative samples in at least one 
domain. Unclear when norms of HC 
scores were used. 
UKPDS (Hughes et al., 
1992) 
52.9 
(27.1)  
EF all 
WM/att 6 of 7 
Verbal all 
Visuospatial all 
 
MCI = Mild Cognitive Impairment; DLB = Dementia with Lewy Bodies; AD = Alzheimer’s disease; PD = Parkinson’s disease; HC = healthy controls; MMSE = Mini Mental State 
Examination; UKPDS = UK Parkinson’s Disease Society; MDS = Movement Disorder Society; SD = standard deviation; EF = executive function; WM/att = working memory/attention. 
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Table 2: Summary of impairments in Parkinson’s disease with Mild Cognition Impairment (PD-MCI) from retained paper (n=13) across neuropsychological domains. 
PD-MCI group Control group Domain Proportion of studies with at 
least one impaired variable 
relative to controls 
Proportion of outcome 
variables impaired relative to 
controls 
n Age 
Mean (SD) 
n Age 
Mean (SD) 
530 63.8 (8.3) 840 61.7 (9.3) Executive function 100% (13/13) 89% (39/44) 
WM/Attention 88.9% (8/9) 68% (21/31) 
Visuospatial L&M 88.9% (8/9) 91% (30/33) 
Visuospatial WM 75.0% (3/4) 67% (4/6) 
Verbal L&M 100% (11/11) 88% (30/34) 
MCI-LB group Control group    
n Age 
Mean (SD) 
n Age 
Mean (SD) 
Domain Proportion of studies with at 
least one impaired variable 
relative to controls 
Proportion of outcome 
variables impaired relative to 
controls 
37 67.2 (8.6) 29 68.8 (7.9) Executive function 100.0% (1/1) 100.0% (4/4) 
WM/Attention 100.0% (1/1) 50.0% (2/4) 
Visuospatial L&M 100.0% (1/1) 55.6% (5/9) 
Visuospatial WM - - 
Verbal L&M 100.0% (1/1) 100.0% (3/3) 
MCI-LB group MCI-AD group Domain Proportion of studies with at 
least one impaired variable 
relative to controls 
Proportion of outcome 
variables impaired relative to 
controls 
n Age 
Mean (SD) 
n Age 
Mean (SD) 
133 76.0 (7.92) 241 75.0 (8.0) Executive function 83.3% (5/6) 43.8% (7/16) 
WM/Attention 67.0% (4/6) 25.0% (5/20) 
Visuospatial L&M 60.0% (3/5) 42.9% ( (9/21) 
Visuospatial WM 100.0% (1/1) 100.0% (1/1) 
Verbal L&M 0.0% (0/6) 0.0% (0/20) 
SD = standard deviation; PD = Parkinson’s Disease; MCI = Mild Cognitive Impairment; WM = working memory, L&M = learning and memory. 
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Table 3: Results of tests for commonly reported outcome measures for PD-MCI participants.  
Domain Outcome measure Studies Patient n Control n Std. Mean Difference [95% CI] Test for overall effect Heterogeneity 
EF Card sorting - categories achieved 4 136 224 -1.30 [-1.55, -1.04] Z = 9.93 (p<.001) Chi² = 3.36, df = 3 (p = .34); I² = 11% 
Card sorting - perseverative errors 4 110 204 -0.63 [-0.89, -0.37] Z = 4.72 (p<.001) Chi² = 0.07, df = 2 (p = .97); I² = 0% 
Phonemic Fluency 6 267 384 -0.85 [-1.02, -0.67] Z = 9.48 (p<.001) Chi² = 9.58, df = 5 (p = .09); I² = 48% 
Semantic Fluency 8 379 748 -1.07 [-1.21, -0.93] Z = 14.90 (p<.001) Chi² = 131.77, df = 7 (p < .001); I² = 95% 
Stroop interference condition 3 127 288 -0.73 [-0.95, -0.51] Z = 6.54 (p<.001) Chi² = 3.81, df = 2 (p = .15); I² = 48% 
 TMT B 4 151 188 -1.65 [-1.93, -1.37] Z = 11.51 (p<.001) Chi² = 7.74, df = 3 (p = .05); I² = 61% 
WM Digit Span Forwards 5 257 318 -0.69 [-0.87, -0.51] Z = 7.47 (p<.001) Chi² = 32.25, df = 4 (p < .001); I² = 88% 
Digit Span Backwards 5 234 320 -0.52 [-0.70, -0.35] Z = 5.78 (p<.001) Chi² = 7.99, df = 4 (p = .09); I² = 50% 
TMT A 5 195 272 -1.20 [-1.42, -0.98] Z = 10.67 (p<.001) Chi² = 20.33, df = 4 (p < .001); I² = 80% 
Verbal Naming tasks 6 220 468 -1.40 [-1.59, -1.21] Z = 14.50 (p<.001) Chi² = 36.80, df = 5 (p < .001); I² = 86% 
 Word list (immediate free recall) 5 195 341 -0.96 [-1.15, -0.76] Z = 9.53 (p<.001) Chi² = 28.61, df = 4 (p < .001); I² = 86% 
 Word list (delayed free recall) 7 257 411 -1.25 [-1.43, -1.08] Z = 13.80 (p<.001) Chi² = 9.31, df = 6 (p = .16); I² = 36% 
Word list (recognition) 3 142 216 -0.07 [-0.29, 0.14] Z = 0.69 (p=.49) Chi² = 0.39, df = 2 (p = .82); I² = 0% 
Word list (similarities) 3 189 265 -0.50 [-0.70, -0.30] Z = 4.97 (p<.001) Chi² = 3.44, df = 2 (p = .18); I² = 42% 
VS Benton JOLO 4 176 333 -2.09 [-2.33, -1.85] Z = 17.28 (p<.001) Chi² = 56.06, df = 3 (p < .001)); I² = 95% 
Figure copy 4 283 481 -1.56 [-1.74, -1.38] Z = 16.68 (p=.003) Chi² = 153.64, df = 3 (p = .18); I² = 98% 
Drawing – immediate recall 4 130 237 -0.94 [-1.19, -0.70] Z = 7.57 (p<.001) Chi² = 13.28, df = 3 (p = .004); I² = 77% 
Drawing – delayed recall 7 305 585 -1.03 [-1.19, -0.87] Z = 12.79 (p<.001) Chi² = 25.83, df = 6 (p < .001); I² = 77% 
ROCF 6 231 258 -1.42 [-1.65, -1.19] Z = 12.24 (p<.001) Chi² = 93.53, df = 5 (p < .001); I² = 95% 
PD = Parkinson’s Disease; MCI = Mild Cognitive Impairment; EF = executive function; WM = working memory; VS = visuospatial; TMT = Trail Making Test; JOLO = judgement of line 
orientation; ROCF = Rey-Osterrieth complex figure. 
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Figure Legends 
 
Fig 1 a and b. Bias-corrected effect sizes of (a) phonemic verbal fluency scores and (b) semantic verbal fluency scores in PD-MCI relative to controls in individual studies (circles) and 
as a summary effect size by group (diamonds).  
 
Fig. 2. Bias-corrected effect sizes of visuospatial copying and recall tasks in PD-MCI relative to controls in both individual studies (circles) and as a summary effect size by group 
(diamonds). (BVMT = Brief Visuospatial Memory Test; ROCF = Rey-Osterrieth Complex Figure). 
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